A recently developed technology called DARC (Detection of Apoptosing Retinal Cells) identifies cellular level disease activity in the retina.
Developed by UCL Professor of Glaucoma and Retinal Neurodegeneration Francesca Cordeiro, the technology, when supported by an artificial intelligence (AI) algorithm, could help accelerate clinical trials. Eventually it may be used in detection and diagnostics, as described in the Wellcome-funded study published in Expert Review of Molecular Diagnostics today.
The test involves injecting into the bloodstream (via the arm) a fluorescent dye that attaches to retinal cells, and illuminates those that are in the process of apoptosis, a form of programmed cell death. The damaged cells appear bright white when viewed in eye examinations — the more damaged cells detected, the higher the DARC count
Prof Cordeiro said:
These results are very promising as they show DARC could be used as a biomarker when combined with the AI-aided algorithm. What is really exciting, and actually unusual when looking at biological markers, is that there was a clear DARC count threshold above which all glaucoma eyes went on to progress
First author Dr Eduardo Normando (Imperial College London and Western Eye Hospital Imperial College Healthcare NHS Trust) said:
Being able to diagnose glaucoma at an earlier stage, and predict its course of progression, could help people to maintain their sight, as treatment is most successful if provided at an early stage of the disease. After further research in longitudinal studies, we hope that our test could have widespread clinical applications for glaucoma and other conditions.
- View the study on Expert Review of Molecular Diagnostics
Sponsor the Behaviour Change Conference
Join us in shaping the future of behaviour change.
21 Dec 2026
UCL GBSH Pride Month panel explores inclusive leadership in a changing world
The UCL GBSH EDI committee brought students, staff and health leaders together to explore inclusive leadership, organisational culture and the need to value authenticity in healthcare for Pride Month.
17 Jun 2026
The Roche Scholarship for UCL MBA Health renewed for two years to support future UK health leaders
UCL GBSH and Roche UK renew The Roche Scholarship for 2026 and 2027, funding one UK student annually from underrepresented backgrounds with full fees to support future healthcare leaders.
17 Jun 2026